DOSAGE AND ADMINISTRATION
ribose)polymerase(PARP)inhibitor indicated as monotherapy in patients with deleterious or suspected deleterious germ line BRCA mutated (as detected by an FDA-approved test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy DOSAGE AND ADMINISTRATION The recommended dose of Olaparib is 300 mg (two 150 mg